查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466567

月經藥物市場：按類型、治療方法、分銷管道和最終用戶分類 - 全球預測 2024-2030

Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年月經治療市場規模為71.6億美元，2024年達78億美元，預計2030年將達130.9億美元，複合年成長率為8.98%。

月經藥物是指控制和緩解與月經和月經疼痛相關的疼痛和不適的治療方法。月經是一種常見疾病，其特徵是在月經月經之前發生腹部絞痛，影響很大一部分月經個體。經月經的治療方法旨在減輕疼痛、改善生活品質並盡量減少對日常生活的干擾。同時，人們對婦女生殖健康的認知不斷提高，政府支持婦女保健機構的措施和計畫也為擴大月經相關治療做出了重大貢獻。醫療保健營業單位增加的臨床試驗和大量投資也有助於月經藥物和診斷方法的大規模供應。然而，缺乏與月經止痛藥物相關的報銷政策和嚴格規定，給經月經藥物提供者帶來了重大挑戰。公司不斷降低治療成本並投資新藥研究工作，以在不斷變化的市場環境中保持競爭力。此外，月經治療的最新進展以及穿戴式科技和數位醫療服務的日益採用也常常有助於月經藥物未來的擴張。此外，由人工智慧和機器學習提供支援的資料主導的見解可以幫助制定個人化的治療計劃並確定可導致經月經醫學新治療性介入的模式。

主要市場統計
基準年[2023] 71.6億美元
預測年份 [2024] 78億美元
預測年份 [2030] 130.9億美元
複合年成長率（%） 8.98%

原發性經痛類型的廣泛發生和疼痛緩解管理的廣泛需求

原發性經痛是由子宮收縮和月經期間Gland釋放引起的，高達 90% 的女性都會經歷這種情況。月經的主要治療方法是緩解疼痛和控制疼痛。其他治療方法包括幫助調節荷爾蒙水平的口服避孕藥、緩解肌肉緊張的熱療以及運動和減輕壓力等生活方式的改變。次發性月經是由子宮內膜異位症、發炎或子宮肌瘤等潛在疾病引起的月經痛。治療次發性月經的藥物需要專注於緩解症狀，同時解決疼痛的根本原因。續發性月經的治療方法取決於具體的疾病。子宮內膜異位症的治療包括荷爾蒙療法、腹腔鏡手術等外科手術和發炎藥物。如果發炎是續發性月經的根本原因，通常會開抗生素來治療感染疾病。

治療 以子宮切除術治療永久緩解月經

藥物往往是治療月經的首選。非類固醇消炎劑(NSAID)，例如Ibuprofen和萘普生，可以有效減輕與月經來潮相關的疼痛和發炎。這些藥物可在櫃檯購買或由醫療保健專業人員處方。手術介入治療僅限於因子宮內膜異位症或子宮肌瘤等潛在疾病而加劇經月經的患者。腹腔鏡手術是微創手術，可以有效去除引起疼痛的沾黏和肌瘤。在極端情況下，子宮切除術（包括切除子宮）可以永久緩解月經。此外，心理介入有助於解決與月經相關的心理困擾並提高整體應對能力。最常使用的心理療法包括認知行為療法（CBT）、放鬆技巧（深呼吸、漸進式肌肉放鬆）和生物回饋療法（監測心率變異性、肌肉張力和皮膚溫度等生理過程）。此外，各種非藥理學的處置方法越來越受歡迎，因為它們在控制月經症狀方面具有潛在的好處，而且不會引起明顯的副作用。很少有替代療法，例如針灸、經皮神經電刺激 (TENS)、芳香療法、瑜伽和營養補充，可以為那些尋求非藥物方法來控制月經症狀的患者提供多種選擇。患者提供全面的護理選擇。

分銷管道：藥品和止痛貼片的便利性、自由裁量權和有競爭力的價格正在推動人們對網路藥局的偏好。

在月經的治療中，醫院藥局對於立即為患者提供正確的藥物至關重要。醫院藥房出售治療各種類型月經的非處方藥 (OTC) 和處方成藥，包括非類固醇消炎劑(NSAID)、鎮痛藥、解痙藥和荷爾蒙藥物，包括口服避孕藥。月經藥局因其便利性、可自由裁量權和有競爭力的價格而越來越受歡迎。此線上平台提供各種產品，包括傳統成藥和草藥補充品和熱貼等替代療法。網路藥局是重視隱私或居住在無法進入實體店的偏遠地區的人們的最愛。零售藥局仍然是月經藥物的重要分銷管道，因為它們可以輕鬆獲得藥物，而無需事先預約醫療保健專業人員。這些藥房備有各種非處方藥，包括Ibuprofen、萘普生和阿斯匹靈。零售藥局迎合那些喜歡與藥劑師面對面接觸以獲得個人化建議和建議的消費者。

最終用戶：由於易於獲取和成本效益，家庭護理領域擴大採用月經藥物

在居家照護領域，最終使用者更喜歡易於取得且具成本效益的治療方案來控制月經症狀。這包括非類固醇消炎劑(NSAID)、Ibuprofen和萘普生等成藥)以及熱療和草藥補充品等自然療法。家庭護理還包括瑜伽、針灸和按摩等替代療法，這些療法在緩解月經痛方面已顯示出良好的效果。最終用戶更喜歡醫院來治療嚴重月經，因為它需要更多的重症監護和先進的干涉措施。對於患有導致嚴重月經症狀的潛在婦科疾病的患者，也可能建議進行手術治療。子宮內膜異位症相關的月經痛可以由醫院的專業婦科醫生透過腹腔鏡手術治療。專科診所為最終使用者尋求了解女性健康問題的醫療專業人員（例如婦科醫生、生殖內分泌科醫生和骨盆疼痛專家）的專門治療提供服務。這些診所提供個人化的治療計劃，包括處方藥、荷爾蒙療法、物理治療和心理諮詢。

區域洞察

在美洲國家，包括美國和加拿大，很大一部分女性人口經歷月經疼痛，包括月經。隨著這些國家對婦女健康問題的認知不斷提高，人們正在做出各種努力來研究和開發針對這種情況的有效治療方法。歐盟 (EU) 國家擁有先進的醫療保健系統，優先考慮女性健康，並為經月經治療方案的研究提供大量資金。例如，歐洲藥品管理局（EMA）已在歐洲國家核准了多種針對緩解月經疼痛的藥物。此外，中國、日本和印度是亞太地區月經藥物的主要市場，因為這些國家有大量遭受月經痛的女性。在這些國家，傳統醫學在解決月經發揮著重要作用。此外，該地區正在進行研究，以探索針灸和艾灸等替代療法治療月經的有效性。在日本，傳統醫學和現代醫學結合的方法被用來解決女性的健康問題，並開立洛索洛芬等專利藥物來緩解月經疼痛。在印度，人們對婦女健康問題的認知不斷提高，導致對月經衛生管理的投資增加，並增加了獲得負擔得起的醫療保健的機會。根據文化因素、醫療基礎設施和對女性健康問題的認知，全球對有效月經治療的需求因地區而異。研究和開發的創新為推進月經治療藥物的選擇提供了有希望的機會。

FPNV定位矩陣

FPNV定位矩陣對於評估月經治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對經月經藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.月經治療藥物市場規模及預測是多少？

2.月經治療藥物市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.月經治療藥物市場的技術趨勢和法規結構是什麼？

4.月經治療藥物市場主要廠商的市場佔有率為何？

5.進入經月經藥市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 月經的盛行率以及有效治療方法的必要性
      • 人們對婦女生殖健康的認知不斷提高，政府努力擴大婦女的醫療保健
    • 抑制因素
      • 月經藥品及醫療設備產品召回相關問題
    • 機會
      • 月經治療的進展和新藥的出現
      • 穿戴式科技的引入和數位健康的普及
    • 任務
      • 關於月經治療的社會障礙與恥辱
  • 市場區隔分析
    • 類型：原發性經痛很常見，需要廣泛的止痛治療。
    • 治療：以子宮切除治療，永久緩解月經
    • 分銷管道：由於藥品和止痛貼片的便利性、保密性和有競爭力的價格，線上藥局越來越受到青睞。
    • 最終用戶：易於取得和成本效益導致家庭護理領域擴大採用月經藥物。
  • 市場趨勢分析
    • 美洲的特點是先進的製藥選擇和Start-Ups創新的成長，旨在提供個人化、數位化和以患者為中心的解決方案。
    • 提高女性健康意識需要在全部區域大規模臨床試驗並將經月經治療商業化
    • 監理合規重點在於 EMEA 地區月經治療藥物的資金籌措、研發、臨床試驗和核准。
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章月經治療藥物市場：依類型

  • 原發性經痛
  • 次發性月經

第7章月經治療藥物市場：依治療方法分類

  • 藥品
  • 外科手術
  • 治療藥物

第8章月經治療藥物市場：按分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章月經治療藥物市場：依最終使用者分類

  • 居家護理
  • 醫院
  • 專科診所

第10章 北美和南美月經治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太月經治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的月經藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Mithra 申請在日本上市用於核准月經
    • Chime Biologics與Hope Medicine簽署生產協議，加速推出首個針對子宮內膜異位症和雄性禿的抗體醫藥品HMI-115
    • Mithra 從富士製藥接受250 萬歐元用於日本月經治療
    • 住友製藥和輝瑞公司在加拿大獲得加拿大衛生署核准MYFEMBREE
    • Gedeon Richter 和住友製藥獲得 CHMP 對子宮內膜異位症治療 RYEQO 的正面意見
    • 蒙特婁的新技術可以幫助緩解經期疼痛
    • 中外製藥和 Bioformis 建立新的合作夥伴關係，專注於資料驅動的虛擬護理，治療與子宮內膜異位症相關的疼痛
    • Dare Bioscience開始治療原發性經痛的一期試驗
    • 健康科技Start-UpsOvira 正在幫助女性解決無需藥物即可緩解疼痛的重要問題。
    • 憑藉新的美麗靈感設計和擴展的健康產品組合，Cora 重新構想了經期護理，讓每個人都感覺更好。

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-742BD517DA92

[189 Pages Report] The Dysmenorrhea Treatment Market size was estimated at USD 7.16 billion in 2023 and expected to reach USD 7.80 billion in 2024, at a CAGR 8.98% to reach USD 13.09 billion by 2030.

Dysmenorrhea treatment refers to the therapeutic approaches for managing and alleviating the pain and discomfort associated with dysmenorrhea or menstrual cramps. Dysmenorrhea is a prevalent condition affecting a significant proportion of menstruating individuals, characterized by painful abdominal cramping that occurs during or before their menstrual periods. The treatments for treating dysmenorrhea aim to reduce the pain, improve quality of life, and minimize disruption to daily activities. Meanwhile, the rising awareness about women's reproductive health and government initiatives & programs supporting healthcare facilities for women contribute significantly to the expansion of dysmenorrhea-related treatments. The increasing number of clinical trials and huge investments by healthcare entities have also contributed to the large-scale dysmenorrhea treatments & diagnosis. However, the lack of reimbursement policies and strict regulations associated with the drugs for menstrual pains is a significant challenge for dysmenorrhea treatment providers. Companies are continuously working toward cutting treatment costs and investing in research activities for novel medications to remain competitive in this evolving market landscape. Moreover, the recent advancements in the therapy of dysmenorrhea and increasing adoption of wearable technology along with digital health services are frequently contributing to the future expansion of dysmenorrhea treatment. Additionally, harnessing data-driven insights using artificial intelligence and machine learning can also aid in developing personalized treatment plans and identifying patterns leading to new therapeutic interventions in dysmenorrhea treatments.

KEY MARKET STATISTICS
Base Year [2023] USD 7.16 billion
Estimated Year [2024] USD 7.80 billion
Forecast Year [2030] USD 13.09 billion
CAGR (%) 8.98%

Type: Wide occurrence of primary dysmenorrhea and extensive need for pain relief management

Primary dysmenorrhea is experienced by up to 90% of women which is caused by uterine contractions and prostaglandin release during menstruation. The need for primary dysmenorrhea treatment mainly revolves around pain relief and management. Additional treatments include oral contraceptives that help regulate hormone levels, heat application to ease muscle tension, and lifestyle modifications such as exercise and stress reduction. Secondary dysmenorrhea is menstrual pain caused by an underlying medical condition, including endometriosis, pelvic inflammatory disease, or uterine fibroids. The need for secondary dysmenorrhea treatment focuses on addressing the root cause of the pain while also providing symptom relief. The treatment options for secondary dysmenorrhea vary depending on the specific medical condition. Endometriosis treatments may include hormonal therapy, surgical interventions such as laparoscopic surgery, and anti-inflammatory medications. The cases having pelvic inflammatory disease is the underlying cause of secondary dysmenorrhea, antibiotics are often prescribed to treat the infection.

Treatment: Adoption of hysterectomy treatment to provide permanent relief from dysmenorrhea

Medications are often the first line of treatment for dysmenorrhea. Nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen and naproxen, effectively reduce pain and inflammation associated with menstrual cramps. These medications are purchased over the counter or prescribed by a healthcare professional. Surgical intervention treatment is reserved for patients with severe dysmenorrhea caused by underlying conditions such as endometriosis or uterine fibroids. Laparoscopic surgery is minimally invasive and can effectively remove adhesions or fibroids causing the pain. In extreme cases, a hysterectomy, which is the removal of the uterus, may be performed to provide permanent relief from dysmenorrhea. Moreover, psychological interventions can be beneficial in addressing the emotional distress linked to dysmenorrhea and enhancing overall coping abilities. Most used psychological therapies include cognitive behavioral therapy (CBT), relaxation techniques (deep breathing, progressive muscle relaxation), and biofeedback (monitoring physiological processes such as heart rate variability, muscle tension, or skin temperature). Furthermore, various non-pharmacological approaches have gained popularity due to their potential benefits in managing dysmenorrhea symptoms without causing significant side effects. Few alternative treatments, including acupuncture, transcutaneous electrical nerve stimulation (TENS), aromatherapy, yoga, and dietary supplements, offer a variety of options for individuals seeking non-pharmacological methods to manage dysmenorrhea symptoms and provide comprehensive care options for patients experiencing menstrual pain.

Distribution Channel: Growing preference for online pharmacies due to their convenience, discreteness, and competitive pricing of medications and pain relief patches

In treating dysmenorrhea, hospital pharmacies are crucial in providing patients with immediate and appropriate medication. Hospital pharmacies often have a wide range of over-the-counter (OTC) and prescription medications to treat various types of dysmenorrhea, including nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, antispasmodics, and hormonal treatments, including oral contraceptives. Online pharmacies are increasingly popular for purchasing dysmenorrhea treatments due to their convenience, discreteness, and competitive pricing. Online platforms offer a variety of products, including traditional OTC medications and alternative remedies such as herbal supplements and heat patches. The preference for online pharmacies is higher among those seeking privacy or living in remote areas with limited access to physical retail outlets. Retail pharmacies remain an essential distribution channel for dysmenorrhea treatments as they offer easy access to medication without needing a prior appointment with a healthcare professional. These pharmacies stock various OTC medications, including ibuprofen, naproxen, and aspirin. Retail pharmacies cater to consumers preferring face-to-face interaction with pharmacists for personalized advice and recommendations.

End-Users: Increasing adoption of dysmenorrhea treatment in the homecare segment as it is easily accessible and cost-effective

In the homecare sector, end-users prefer easily accessible and cost-effective treatment options to manage dysmenorrhea symptoms. These include over-the-counter (OTC) medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, and naproxen, and natural remedies, including heat therapy and herbal supplements. Homecare also involves alternative therapies such as yoga, acupuncture, and massage that have shown promising results in alleviating menstrual pain. End-users prefer hospitals in need of more intensive care or advanced interventions for treating severe cases of dysmenorrhea. Surgical treatments may also be recommended in patients with underlying gynecological conditions contributing to severe dysmenorrhea symptoms. Endometriosis-related menstrual pain can be treated in laparoscopic surgery by specialized gynecological surgeons in hospitals. Specialty clinics cater to end-users seeking specialized care from healthcare professionals with expertise in women's health issues, such as gynecologists, reproductive endocrinologists, and pelvic pain specialists. These clinics offer personalized treatment plans, including prescription medications, hormonal therapy, physical therapy, or psychological counseling.

Regional Insights

In American countries, including the United States and Canada, a large percentage of the female population experiences menstrual cramps, including dysmenorrhea. These countries witness various efforts to research and develop effective treatments for this condition with greater awareness of women's health issues. European Union countries have advanced healthcare systems that prioritize women's health, leading to significant funding for research on dysmenorrhea treatment options. For instance, the European Medicines Agency (EMA) has approved various medications targeting menstrual pain relief across European countries. Furthermore, China, Japan, and India are key markets within the Asia-Pacific region for dysmenorrhea treatment due to their large populations of women experiencing menstrual pain. Traditional medicine plays a crucial role in addressing dysmenorrhea in these countries. Moreover, research initiatives in this region explore the efficacy of alternative therapies, such as acupuncture and moxibustion, in treating dysmenorrhea. In Japan, a mix of traditional and modern medical approaches is adopted to address women's health issues, with patented medications such as Loxoprofen being prescribed for menstrual pain relief. India has observed an increase in investment in menstrual hygiene management and access to affordable healthcare with its growing awareness about women's health issues. The need for effective dysmenorrhea treatments worldwide varies across regions based on cultural factors, healthcare infrastructure, and awareness about women's health issues. Innovations in research and development provide promising opportunities for advancements in dysmenorrhea treatment options.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Dysmenorrhea Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dysmenorrhea Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Dysmenorrhea Treatment Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Abbott Laboratories, AbbVie Inc., Alfa Pharma GmbH, Alvogen, Inc., ASKA Pharmaceutical Co., Ltd., Bayer AG, Comforte Cream by PMS4PMS, LLC, Cora Life by LYV Life, Inc., Cumberland Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Ferring B.V., Gedeon Richter Plc., GlaxoSmithKline PLC, Haleon PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LGM Pharma, Livia by iPulse Medical Ltd., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Micro Labs Limited, Myoovi, Myovant Sciences by Sumitovant Biopharma, Inc., Novartis AG, Ovira, Perrigo Company PLC, Pfizer Inc., Rael, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Dysmenorrhea Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • Treatment
    • Medication
      • Combined Oral Contraceptive Pills
      • Cox-2 Inhibitors
      • Non-Steroidal Anti-Inflammatory Drugs
      • Over-The-Counter Medications
      • Transdermal Glyceryl Trinitrate
    • Surgery
      • Hysterectomy
      • Intrauterine Device
      • Laparoscopic Uterosacral Nerve Ablation
      • Levonorgestrel Intrauterine System (LN-IUS)
      • Presacral Neurectomy
    • Therapeutics
      • Alternative Therapies
      • Psychological Therapies
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End-Users
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Dysmenorrhea Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dysmenorrhea Treatment Market?

3. What are the technology trends and regulatory frameworks in the Dysmenorrhea Treatment Market?

4. What is the market share of the leading vendors in the Dysmenorrhea Treatment Market?

5. Which modes and strategic moves are suitable for entering the Dysmenorrhea Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of dysmenorrhea and the need for effective treatment options
      • 5.1.1.2. Growing awareness about women's reproductive health and government initiatives to expand healthcare for women
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with product recalls for dysmenorrhea drugs and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in therapy for dysmenorrhea and the emergence of novel drugs
      • 5.1.3.2. Adoption of wearable technology and the proliferation of digital health
    • 5.1.4. Challenges
      • 5.1.4.1. Societal barriers and stigmatization regarding dysmenorrhea management
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Wide occurrence of primary dysmenorrhea and extensive need for pain relief management
    • 5.2.2. Treatment: Adoption of hysterectomy treatment to provide permanent relief from dysmenorrhea
    • 5.2.3. Distribution Channel: Growing preference for online pharmacies due to their convenience, discreteness, and competitive pricing of medications and pain relief patches
    • 5.2.4. End-Users: Increasing adoption of dysmenorrhea treatment in the homecare segment as it is easily accessible and cost-effective
  • 5.3. Market Trend Analysis
    • 5.3.1. Strong dysmenorrhea treatment landscape in the Americas characterized by advanced pharmaceutical options and growing innovation by startups, aiming to provide personalized, digital and patient-centered solutions
    • 5.3.2. Rising women's health awareness necessitates extensive clinical trials and dysmenorrhea treatment commercialization across APAC
    • 5.3.3. Regulatory compliance emphasizes the funding, R&D, clinical trials, and approvals for dysmenorrhea treatment in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Dysmenorrhea Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Primary Dysmenorrhea
  • 6.3. Secondary Dysmenorrhea

7. Dysmenorrhea Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medication
  • 7.3. Surgery
  • 7.4. Therapeutics

8. Dysmenorrhea Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Dysmenorrhea Treatment Market, by End-Users

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Americas Dysmenorrhea Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Dysmenorrhea Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Dysmenorrhea Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mithra Submits Marketing Approval Application in Japan to Combat Dysmenorrhea
    • 13.3.2. Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
    • 13.3.3. Mithra to Receive EUR 2.5 Million from Fuji Pharma for Dysmenorrhea Treatment in Japan
    • 13.3.4. Sumitomo Pharma and Pfizer in Canada Receive Health Canada Approval for MYFEMBREE
    • 13.3.5. Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO for Treatment of Endometriosis
    • 13.3.6. How New Tech from Montreal Could Help the Fight Against Period Cramps
    • 13.3.7. Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
    • 13.3.8. Dare Bioscience Begins Phase I Trial of Primary Dysmenorrhea Therapy
    • 13.3.9. Healthtech Startup Ovira is Helping Women Tackle a Key Problem - Drug-Free Period Pain Relief
    • 13.3.10. Cora Reimagines Period Care with a New Beauty-Inspired Look and Expanded Wellness Portfolio to Make Comfort Accessible for Everyone

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DYSMENORRHEA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. DYSMENORRHEA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DYSMENORRHEA TREATMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYSMENORRHEA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE PILLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER-THE-COUNTER MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER-THE-COUNTER MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TRANSDERMAL GLYCERYL TRINITRATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TRANSDERMAL GLYCERYL TRINITRATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPIC UTEROSACRAL NERVE ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPIC UTEROSACRAL NERVE ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LEVONORGESTREL INTRAUTERINE SYSTEM (LN-IUS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LEVONORGESTREL INTRAUTERINE SYSTEM (LN-IUS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESACRAL NEURECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESACRAL NEURECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 330. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 331. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
  • TABLE 332. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 338. VIETNAM DYSMENORRHEA TREATMENT MARK